134 related articles for article (PubMed ID: 25623966)
1. Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury.
Campbell LA; Avdoshina V; Day C; Lim ST; Mocchetti I
Neuropharmacology; 2015 May; 92():98-107. PubMed ID: 25623966
[TBL] [Abstract][Full Text] [Related]
2. Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.
Avdoshina V; Biggio F; Palchik G; Campbell LA; Mocchetti I
Glia; 2010 Oct; 58(13):1630-9. PubMed ID: 20578038
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor is neuroprotective against human immunodeficiency virus-1 envelope proteins.
Bachis A; Mocchetti I
Ann N Y Acad Sci; 2005 Aug; 1053():247-57. PubMed ID: 16179530
[TBL] [Abstract][Full Text] [Related]
4. M-tropic HIV envelope protein gp120 exhibits a different neuropathological profile than T-tropic gp120 in rat striatum.
Bachis A; Cruz MI; Mocchetti I
Eur J Neurosci; 2010 Aug; 32(4):570-8. PubMed ID: 20670282
[TBL] [Abstract][Full Text] [Related]
5. CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal.
Campbell LA; Avdoshina V; Rozzi S; Mocchetti I
Brain Behav Immun; 2013 Nov; 34():130-40. PubMed ID: 23968971
[TBL] [Abstract][Full Text] [Related]
6. The orphan G-protein-coupled receptor 75 signaling is activated by the chemokine CCL5.
Dedoni S; Campbell LA; Harvey BK; Avdoshina V; Mocchetti I
J Neurochem; 2018 Sep; 146(5):526-539. PubMed ID: 29772059
[TBL] [Abstract][Full Text] [Related]
7. Identification of a binding site of the human immunodeficiency virus envelope protein gp120 to neuronal-specific tubulin.
Avdoshina V; Taraballi F; Dedoni S; Corbo C; Paige M; Saygideğer Kont Y; Üren A; Tasciotti E; Mocchetti I
J Neurochem; 2016 Apr; 137(2):287-98. PubMed ID: 26826352
[TBL] [Abstract][Full Text] [Related]
8. Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.
Podhaizer EM; Zou S; Fitting S; Samano KL; El-Hage N; Knapp PE; Hauser KF
J Neuroimmune Pharmacol; 2012 Dec; 7(4):877-91. PubMed ID: 22101471
[TBL] [Abstract][Full Text] [Related]
9. Intrastriatal administration of human immunodeficiency virus-1 glycoprotein 120 reduces glial cell-line derived neurotrophic factor levels and causes apoptosis in the substantia nigra.
Nosheny RL; Bachis A; Aden SA; De Bernardi MA; Mocchetti I
J Neurobiol; 2006 Oct; 66(12):1311-21. PubMed ID: 16967504
[TBL] [Abstract][Full Text] [Related]
10. CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
El-Hage N; Bruce-Keller AJ; Knapp PE; Hauser KF
J Neuroimmune Pharmacol; 2008 Dec; 3(4):275-85. PubMed ID: 18815890
[TBL] [Abstract][Full Text] [Related]
11. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 envelope protein gp120 up regulates CCL5 production in astrocytes which can be circumvented by inhibitors of NF-κB pathway.
Shah A; Singh DP; Buch S; Kumar A
Biochem Biophys Res Commun; 2011 Oct; 414(1):112-7. PubMed ID: 21945445
[TBL] [Abstract][Full Text] [Related]
13. Schwann cell chemokine receptors mediate HIV-1 gp120 toxicity to sensory neurons.
Keswani SC; Polley M; Pardo CA; Griffin JW; McArthur JC; Hoke A
Ann Neurol; 2003 Sep; 54(3):287-96. PubMed ID: 12953261
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 glycoprotein gp120 reduces the levels of brain-derived neurotrophic factor in vivo: potential implication for neuronal cell death.
Nosheny RL; Bachis A; Acquas E; Mocchetti I
Eur J Neurosci; 2004 Dec; 20(11):2857-64. PubMed ID: 15579139
[TBL] [Abstract][Full Text] [Related]
15. The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load.
Caporello E; Nath A; Slevin J; Galey D; Hamilton G; Williams L; Steiner JP; Haughey NJ
J Neurochem; 2006 Jul; 98(1):146-55. PubMed ID: 16805804
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor prevents the nigrostriatal degeneration induced by human immunodeficiency virus-1 glycoprotein 120 in vivo.
Nosheny RL; Ahmed F; Yakovlev A; Meyer EM; Ren K; Tessarollo L; Mocchetti I
Eur J Neurosci; 2007 Apr; 25(8):2275-84. PubMed ID: 17445226
[TBL] [Abstract][Full Text] [Related]
17. Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus-gp120-mediated apoptosis.
Bachis A; Mocchetti I
J Neurosci Res; 2006 Apr; 83(5):890-6. PubMed ID: 16477610
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K
Liu J; Xu E; Tu G; Liu H; Luo J; Xiong H
Mol Cell Neurosci; 2017 Jul; 82():167-175. PubMed ID: 28552341
[TBL] [Abstract][Full Text] [Related]
19. Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation.
Ashraf T; Jiang W; Hoque MT; Henderson J; Wu C; Bendayan R
J Neuroinflammation; 2014 May; 11():91. PubMed ID: 24884548
[TBL] [Abstract][Full Text] [Related]
20. The viral protein gp120 decreases the acetylation of neuronal tubulin: potential mechanism of neurotoxicity.
Avdoshina V; Caragher SP; Wenzel ED; Taraballi F; Mocchetti I; Harry GJ
J Neurochem; 2017 May; 141(4):606-613. PubMed ID: 28295345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
